Physician profile
Paul Joseph Bruner
NPI 1184679995
$3,182.01
in general payments reported to CMS, 2019-2025
39 companies · $562 in 2025
The $562 reported for 2025 was more than what 76% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $378 · 2020: $61.77 · 2021: $184 · 2022: $480 · 2023: $886 · 2024: $629 · 2025: $562.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,078.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,078.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $857.17 | 2021-2025 | Ubrelvy, Qulipta, Vraylar |
| Astrazeneca Pharmaceuticals LP | $361.89 | 2019-2024 | Farxiga, Breztri, Airsupra |
| Pfizer INC. | $229.75 | 2019-2025 | |
| Novo Nordisk INC | $213.17 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $176.80 | 2019-2024 | Mounjaro, Jardiance |
| Exact Sciences Corporation | $127.12 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Xeris Pharmaceuticals, INC. | $103.07 | 2023-2025 | Gvoke Hypopen |
| Tandem Diabetes Care, INC. | $97.71 | 2020-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Amgen INC. | $85.15 | 2019-2025 | Otezla, Repatha, Evenity |
| Dexcom, INC. | $84.62 | 2022-2023 | Dexcom G6 Transmitter |
| Axsome Therapeutics, INC. | $80.68 | 2023-2025 | Auvelity |
| Otsuka America Pharmaceutical, INC. | $77.17 | 2022-2024 | Rexulti |
| Abbott Laboratories | $55.61 | 2022-2025 | Freestyle Libre 3 |
| Sanofi Pasteur INC. | $52.01 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $47.52 | 2019-2024 |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Bruner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.